Enhanced hypoglycemic effects of konjac glucomannan combined with Polygonatum cyrtonema Hua polysaccharide in complete nutritional liquid diet fed type 2 diabetes mice

Int J Biol Macromol. 2024 May;266(Pt 1):131121. doi: 10.1016/j.ijbiomac.2024.131121. Epub 2024 Mar 22.

Abstract

In our aging society, dysphagia and malnutrition are growing concerns, necessitating intervention. Liquid nutrition support offers a practical solution for traditional dietary issues, but it raises a key issue: the potential for post-meal glucose spikes impacting efficacy. This study examined the effects of supplementation of Polygonatum cyrtonema Hua polysaccharide (PCP), konjac glucomannan (KGM) and their combination on acute phase postprandial glycemic response and long-term glucose metabolism in T2DM mice on a complete nutritional liquid diet. KGM was more effective in reducing postprandial glucose response, while PCP was more prominent in ameliorating long-term glucose metabolism. The KGM-PCP combination demonstrated superior outcomes in fasting blood glucose, insulin, and glucose homeostasis. PCP and KGM also influenced the composition and abundance of the gut microbiome, with the H-PCP group showing optimal performance. Moreover, the KGM-PCP combination improved body weight, lipid homeostasis, and liver health the most. PCP potentially regulates glycemia through metabolic pathways, while KGM improves glycemic metabolism by reducing postprandial glucose levels in response to viscous intestinal contents. This research identifies the structure, viscosity properties, and hypoglycemic effects of KGM and PCP in complete nutritional liquid diet fed T2DM mice, enabling their strategic utilization as hypoglycemic components in nutritional administration and glycemic regulation.

Keywords: Complete nutritional liquid diet; Glucose metabolism; Gut microbiome; Konjac glucomannan; Polygonatum cyrtonema Hua polysaccharide.

MeSH terms

  • Animals
  • Blood Glucose* / metabolism
  • Body Weight / drug effects
  • Diabetes Mellitus, Experimental / diet therapy
  • Diabetes Mellitus, Experimental / drug therapy
  • Diabetes Mellitus, Type 2* / diet therapy
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetes Mellitus, Type 2* / metabolism
  • Gastrointestinal Microbiome / drug effects
  • Hypoglycemic Agents* / chemistry
  • Hypoglycemic Agents* / pharmacology
  • Insulin / blood
  • Insulin / metabolism
  • Male
  • Mannans* / chemistry
  • Mannans* / pharmacology
  • Mice
  • Polygonatum* / chemistry
  • Polysaccharides* / administration & dosage
  • Polysaccharides* / chemistry
  • Polysaccharides* / pharmacology

Substances

  • (1-6)-alpha-glucomannan
  • Mannans
  • Polysaccharides
  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin